|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 93 No. 1 (January 1), 1999:
pp. 113-124
Tyrosine-Dependent and -Independent Mechanisms of STAT3
Activation by the Human Granulocyte Colony-Stimulating Factor
(G-CSF) Receptor Are Differentially Utilized Depending on G-CSF
Concentration
Alister C. Ward,
Mirjam H.A. Hermans,
Louise Smith,
Yvette M. van
Aesch,
Anita M. Schelen,
Claudia Antonissen, and
Ivo P. Touw
From the Institute of Hematology, Erasmus University, Rotterdam; and
the Department of Hematology, Dr Daniel den Hoed Cancer Center,
Rotterdam, The Netherlands.
The granulocyte colony-stimulating factor receptor
(G-CSF-R) activates multiple STAT proteins. Although the
membrane-proximal cytoplasmic region of the G-CSF-R is necessary and
sufficient for activation of STAT1 and STAT5, activation of STAT3
requires the membrane distal region that contains four tyrosines.
Although one of these (Y704) has previously been shown to be involved
in STAT3 activation from a truncated G-CSF-R derived from a patient with severe chronic neutropenia (SCN), this tyrosine is not required for STAT3 activation by the full-length G-CSF-R. To investigate possible alternative mechanisms of STAT3 activation, we generated a
series of Ba/F3 cell transfectants expressing the wild-type G-CSF-R or
mutant receptors that either completely lack tyrosines or retain just
one of the four cytoplasmic tyrosines of the G-CSF-R. We show that, at
saturating G-CSF concentrations, STAT3 activation from the full-length
G-CSF-R is efficiently mediated by the C-terminal domain in a manner
independent of receptor tyrosines. In contrast, at low G-CSF
concentrations, Y704 and Y744 of the G-CSF-R play a major role in STAT3
activation. Both tyrosine-dependent and -independent mechanisms of
STAT3 activation are sensitive to the Jak2 inhibitor AG-490, follow
similar kinetics, and lead to transactivation of a STAT3 reporter
construct, indicating functional equivalence. STAT3 activation is also
impaired, particularly at nonsaturating G-CSF concentrations, in bone
marrow cells from mice expressing a truncated G-CSF-R
(gcsfr- 715). These findings suggest that G-CSF-induced STAT3 activation during basal granulopoiesis (low G-CSF)
and "emergency" granulopoiesis (high G-CSF) are differentially controlled. In addition, the data establish the importance of the
G-CSF-R C-terminus in STAT3 activation in primary cells, which has
implications for understanding why truncated G-CSF-R derived from SCN
patients are defective in maturation signaling.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
K. Jiang, N. Hein, K. Eckert, J. Luscher-Firzlaff, and B. Luscher
Regulation of the MAD1 promoter by G-CSF
Nucleic Acids Res.,
March 1, 2008;
36(5):
1517 - 1531.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Germeshausen, M. Ballmaier, and K. Welte
Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: results of a long-term survey
Blood,
January 1, 2007;
109(1):
93 - 99.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Hoogendam, E. Parlevliet, R. Miclea, C. W. G. M. Lowik, J. M. Wit, and M. Karperien
Novel Early Target Genes of Parathyroid Hormone-Related Peptide in Chondrocytes
Endocrinology,
June 1, 2006;
147(6):
3141 - 3152.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Khanna-Gupta, H. Sun, T. Zibello, L. Lozovatsky, P. K. Ghosh, D. C. Link, M. L. McLemore, and N. Berliner
p120 nucleolar-proliferating antigen is a direct target of G-CSF signaling during myeloid differentiation
J. Leukoc. Biol.,
May 1, 2006;
79(5):
1011 - 1021.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Hagihara, T. Nishikawa, Y. Sugamata, J. Song, T. Isobe, T. Taga, and K. Yoshizaki
Essential role of STAT3 in cytokine-driven NF-{kappa}B-mediated serum amyloid A gene expression
Genes Cells,
November 1, 2005;
10(11):
1051 - 1063.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G.-J. M. van de Geijn, J. Gits, L. H. J. Aarts, C. Heijmans-Antonissen, and I. P. Touw
G-CSF receptor truncations found in SCN/AML relieve SOCS3-controlled inhibition of STAT5 but leave suppression of STAT3 intact
Blood,
August 1, 2004;
104(3):
667 - 674.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Nishiki, F. Hato, N. Kamata, E. Sakamoto, T. Hasegawa, A. Kimura-Eto, M. Hino, and S. Kitagawa
Selective activation of STAT3 in human monocytes stimulated by G-CSF: implication in inhibition of LPS-induced TNF-{alpha} production
Am J Physiol Cell Physiol,
June 1, 2004;
286(6):
C1302 - C1311.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Q.-S. Zhu, L. J. Robinson, V. Roginskaya, and S. J. Corey
G-CSF-induced tyrosine phosphorylation of Gab2 is Lyn kinase dependent and associated with enhanced Akt and differentiative, not proliferative, responses
Blood,
May 1, 2004;
103(9):
3305 - 3312.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Kimura, I. Kinjyo, Y. Matsumura, H. Mori, R. Mashima, M. Harada, K. R. Chien, H. Yasukawa, and A. Yoshimura
SOCS3 Is a Physiological Negative Regulator for Granulopoiesis and Granulocyte Colony-stimulating Factor Receptor Signaling
J. Biol. Chem.,
February 20, 2004;
279(8):
6905 - 6910.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Guthridge, E. F. Barry, F. A. Felquer, B. J. McClure, F. C. Stomski, H. Ramshaw, and A. F. Lopez
The phosphoserine-585-dependent pathway of the GM-CSF/IL-3/IL-5 receptors mediates hematopoietic cell survival through activation of NF-{kappa}B and induction of bcl-2
Blood,
February 1, 2004;
103(3):
820 - 827.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. H. J. Aarts, O. Roovers, A. C. Ward, and I. P. Touw
Receptor activation and 2 distinct COOH-terminal motifs control G-CSF receptor distribution and internalization kinetics
Blood,
January 15, 2004;
103(2):
571 - 579.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. S. Kendrick, R. J. Lipscombe, O. Rausch, S. E. Nicholson, J. E. Layton, L. C. Goldie-Cregan, and M. A. Bogoyevitch
Contribution of the Membrane-distal Tyrosine in Intracellular Signaling by the Granulocyte Colony-stimulating Factor Receptor
J. Biol. Chem.,
January 2, 2004;
279(1):
326 - 340.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Li, M. P. Menon, V. G. Karur, S. Hegde, and D. M. Wojchowski
Attenuated signaling by a phosphotyrosine-null Epo receptor form in primary erythroid progenitor cells
Blood,
November 1, 2003;
102(9):
3147 - 3153.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Santini, B. Scappini, Z. K. Indik, A. Gozzini, P. Rossi Ferrini, and A. D. Schreiber
The carboxy-terminal region of the granulocyte colony-stimulating factor receptor transduces a phagocytic signal
Blood,
June 1, 2003;
101(11):
4615 - 4622.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. H. A. Hermans, G.-J. van de Geijn, C. Antonissen, J. Gits, D. van Leeuwen, A. C. Ward, and I. P. Touw
Signaling mechanisms coupled to tyrosines in the granulocyte colony-stimulating factor receptor orchestrate G-CSF-induced expansion of myeloid progenitor cells
Blood,
April 1, 2003;
101(7):
2584 - 2590.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Q.-f. Wang and A. D. Friedman
CCAAT/enhancer-binding proteins are required for granulopoiesis independent of their induction of the granulocyte colony-stimulating factor receptor
Blood,
April 15, 2002;
99(8):
2776 - 2785.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. L. Hevehan, W. M. Miller, and E. T. Papoutsakis
Differential expression and phosphorylation of distinct STAT3 proteins during granulocytic differentiation
Blood,
March 1, 2002;
99(5):
1627 - 1637.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Akbarzadeh, A. C. Ward, D. O. M. McPhee, W. S. Alexander, G. J. Lieschke, and J. E. Layton
Tyrosine residues of the granulocyte colony-stimulating factor receptor transmit proliferation and differentiation signals in murine bone marrow cells
Blood,
February 1, 2002;
99(3):
879 - 887.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. F. Duarte and D. A. Frank
SCF and G-CSF lead to the synergistic induction of proliferation and gene expression through complementary signaling pathways
Blood,
November 15, 2000;
96(10):
3422 - 3430.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. C. Ward, I. Touw, and A. Yoshimura
The Jak-Stat pathway in normal and perturbed hematopoiesis
Blood,
January 1, 2000;
95(1):
19 - 29.
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. Wang, H. Fjerdingstad, I. Strøm-Gundersen, and H. B. Benestad
Maturation Rate of Mouse Neutrophilic Granulocytes: Acceleration by Retardation of Proliferation, but No Detectable Influence from G-CSF or Stromal Cells
Stem Cells,
September 1, 1999;
17(5):
253 - 264.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
A. C. Ward, Y. M. van Aesch, J. Gits, A. M. Schelen, J. P. de Koning, D. van Leeuwen, M. H. Freedman, and I. P. Touw
Novel Point Mutation in the Extracellular Domain of the Granulocyte Colony-stimulating Factor (G-CSF) Receptor in a Case of Severe Congenital Neutropenia Hyporesponsive to G-CSF Treatment
J. Exp. Med.,
August 16, 1999;
190(4):
497 - 508.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. C. Ward, L. Smith, J. P. de Koning, Y. van Aesch, and I. P. Touw
Multiple Signals Mediate Proliferation, Differentiation, and Survival from the Granulocyte Colony-stimulating Factor Receptor in Myeloid 32D Cells
J. Biol. Chem.,
May 21, 1999;
274(21):
14956 - 14962.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. H.A. Hermans, C. Antonissen, A. C. Ward, A. E.M. Mayen, R. E. Ploemacher, and I. P. Touw
Sustained Receptor Activation and Hyperproliferation in Response to Granulocyte Colony-stimulating Factor (G-CSF) in Mice with a Severe Congenital Neutropenia/Acute Myeloid Leukemia-derived Mutation in the G-CSF Receptor Gene
J. Exp. Med.,
February 15, 1999;
189(4):
683 - 692.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. von Lindern, M. P.-v. Amelsvoort, T. van Dijk, E. Deiner, E. van den Akker, S. van Emst-de Vries, P. Willems, H. Beug, and B. Lowenberg
Protein Kinase C alpha Controls Erythropoietin Receptor Signaling
J. Biol. Chem.,
October 27, 2000;
275(44):
34719 - 34727.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. L. Kroll, D. Barth-Baus, and J. O. Hensold
The Carboxyl-terminal Domain of the Granulocyte Colony-stimulating Factor Receptor Uncouples Ribosomal Biogenesis from Cell Cycle Progression in Differentiating 32D Myeloid Cells
J. Biol. Chem.,
December 21, 2001;
276(52):
49410 - 49418.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
